Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	478.39	519.85	615.1	905.45	1,431
Short-Term Investments	-	-	-	-	63.76
Cash & Short-Term Investments	478.39	519.85	615.1	905.45	1,495
Cash Growth	-7.98%	-15.48%	-32.07%	-39.44%	-33.77%
Accounts Receivable	181.91	165.87	149.61	151.71	134.59
Inventory	48.58	62.63	69.02	130.32	123.21
Other Current Assets	29.71	28.28	50.37	71.28	68.07
Total Current Assets	738.59	776.62	884.1	1,259	1,821
Net Property, Plant & Equipment	73.87	100.34	144.2	300.03	406.45
Other Intangible Assets	0.28	0.42	0.96	1.99	5.15
Long-Term Investments	-	-	5.66	5.8	0.91
Other Long-Term Assets	7.63	7.93	5.09	20.89	45.14
Total Assets	820.38	885.31	1,040	1,587	2,279
Accounts Payable	40.74	33.75	18.06	50.95	63.08
Accrued Expenses	80.86	89.5	104.94	173.83	127.89
Short-Term Debt	-	-	-	-	2.37
Current Portion of Long-Term Debt	0.2	-	-	-	-
Current Portion of Leases	16.76	24.57	8.63	37.24	35
Unearned Revenue	107.82	117.9	130.54	147.63	142.87
Other Current Liabilities	0.59	0.59	1.2	1.8	0.97
Total Current Liabilities	246.98	266.3	263.36	411.45	372.18
Long-Term Debt	1.7	-	-	-	-
Long-Term Leases	24.46	27.75	3.69	13.55	49.32
Other Long-Term Liabilities	11.98	10.43	4.54	4.12	11.78
Total Long-Term Liabilities	38.13	38.18	8.23	17.68	61.09
Total Liabilities	285.11	304.48	271.59	429.13	433.28
Common Stock	0.14	0.15	0.14	0.14	0.14
Treasury Stock	-57.19	-63.26	-65.9	-58.92	-
Additional Paid-in Capital	5,010	5,002	4,849	4,583	4,281
Accumulated Other Comprehensive Income	-162.14	-158.05	-161.53	-165.72	-207.07
Retained Earnings	-4,256	-4,200	-3,854	-3,200	-2,229
Shareholders' Equity	535.26	580.83	768.41	1,158	1,845
Total Liabilities & Equity	820.38	885.31	1,040	1,587	2,279
Total Debt	43.12	52.32	12.32	50.79	86.69
Net Cash (Debt)	435.27	467.53	602.77	854.66	1,408
Net Cash Growth	-6.90%	-22.44%	-29.47%	-39.32%	-36.29%
Net Cash Per Share	48.92	54.61	70.86	98.71	162.10
Book Value	535.26	580.83	768.41	1,158	1,845
Book Value Per Share	60.16	67.85	90.33	133.78	212.39
Tangible Book Value	534.98	580.41	767.45	1,156	1,840
Tangible Book Value Per Share	60.12	67.80	90.21	133.55	211.80

Updated Mar 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q